Drugs / Autologous CD34 Positive Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00081913 | Jan 2004 → Mar 2006 | intermediate coronary syndrome, myocardial ischemia | Losordo, Douglas, M.D. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous CD34 Positive Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00081913 ↗ |
| Modality | Cell therapy | “The purpose of this study is to determine if cell therapy with your own cells (autologous cells) delivered with a catheter to regions of the heart with poor blood flow will be...” NCT00081913 ↗ |